com.insightguru.giraffe.server.utils.PresentationUtil$PresentationTitle@84e55bf
This site requires JavaScript to function properly.
For help enabling JavaScript click here.
Here are some sample widgets you could interact with from this dashboard:
(1) Revenues expected to be slightly ahead of consensus estimates
Trefis estimates CME's Q3 2021 revenues to be $1.24 Bil, slightly ahead of the consensus estimate of $1.19 Bil
Estimated Revenues - 2021Q3(E)
Trefis Estimates for CME Group Revenues:
Expected Change (YoY): 14.4%
The chart to the right highlights trends in CME Group's Revenues over the last four quarters along with our forecast for Q3 2021.
Quarterly Revenue Trend
(2) EPS likely to comfortably beat consensus estimates
CME's Q3 2021 earnings per share (EPS) expected to be $1.7 per Trefis analysis, comfortably beating the consensus estimate of $1.61 by 5.6%
Estimated EPS- 2021Q3(E)
Trefis Estimates for CME Group EPS:
Expected Change (YoY): 47.4%
The chart to the right highlights trends in CME's EPS over the last four quarters along with our forecast for Q3 2021.
Quarterly EPS Trend
(3) Stock price estimate largely around current market price
Trefis maintains a fair value of $216 for CME's stock as opposed to the current market price of roughly $218.
CME Stock Price
The Trefis Price Estimate for CME Group stock represents the fair value for the company's stock over a one-year horizon.
Details about the chances of a rise in CME stock in the near term can be found in a separate interactive dashboard.
The chart to the right highlights trends in CME's stock price at the end of each of the last four quarters as well as the current stock price.
Stock Price (Quarter End)
#1. Estimating CME Group's Total Revenues:
CME Group's Revenues have seen a increase of 13.3% from around $4.3 Bil in FY2018 to $4.9 Bil in FY2020 and we expect it to increase to $4.9 Bil in FY2021
Total Revenue
A Separate Interactive Dashboard Analysis On CME Group's Revenues Details How The Company Makes Money.
#2. Deriving CME Group's Adjusted Net Income:
CME Group's Adjusted Net Income has increased from around $2.0 Bil in FY2018 to $2.1 Bil in FY2020 and we expect it to increase to $2.4 Bil in FY2021
This change is likely to be led by higher revenues and improved margins.
A Separate Interactive Dashboard Analysis On CME Group's Margins Highlights The Company's Various Expenses Components In Detail.
Adjusted Net Income [AxB]
Adjusted Net Income Margin [A]
Total Revenue [B]
#3. Determining CME Group's Adjusted EPS:
CME Group's Adjusted EPS has increased from $5.72 in FY2018 to $5.88 in FY2020 and we expect it to increase to $6.61 in FY2021
The change in EPS can be attributed to an increase in adjusted net income and a lower expected share count due to stock repurchases.
Adjusted EPS [A÷B]
Adjusted Net Income [A]
Shares Outstanding [B]
#4. Estimating CME Group's Share Price:
Our Price Estimate of $216 For CME Group's Stock is based on our Detailed Valuation Model, and implies a 32.7x P/E Multiple on expected FY2021 Adjusted EPS of $6.61
Trefis Price Estimate [AxB]
Adjusted EPS [A]
P/E Multiple [B]